Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A3 | P43003 | 1/20 | 0.47 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.47 |
| ▸ | MME | P08473 | 1/20 | 0.47 |
| ▸ | ECE1 | P42892 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 9/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ANPEP | P15144 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.42 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5160238 | 1.00 | SLC1A3 (0.47) | SLC1A3SLC1A1MMEECE1LTA4H | |
| SCHEMBL4541364 | 0.85 | LTA4H (0.58) | SLC1A3SLC1A1LTA4HHTT | |
| SCHEMBL8761303 | 0.85 | LTA4H (0.58) | SLC1A3SLC1A1LTA4HHTT | |
| SCHEMBL10421367 | 0.85 | LTA4H (0.52) | SLC1A3SLC1A1LTA4HHTTLMNA | |
| SCHEMBL11153003 | 0.84 | LTA4H (0.59) | SLC1A3SLC1A1LTA4HHTTLMNA | |
| SCHEMBL7303955 | 0.82 | LTA4H (0.58) | SLC1A3SLC1A1MMEECE1LTA4H | |
| SCHEMBL14864739 | 0.81 | CYP1A2 (0.50) | SLC1A3SLC1A1LTA4H | |
| SCHEMBL10284240 | 0.81 | CYP1A2 (0.50) | SLC1A3SLC1A1LTA4H | |
| SCHEMBL7760121 | 0.80 | LTA4H (0.56) | SLC1A3SLC1A1LTA4HHTTLMNA | |
| SCHEMBL24793050 | 0.80 | ANPEP (0.62) | SLC1A3SLC1A1HTTANPEPDPP8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8846863-B2 | Heat stable protein ingredients | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2014-09-30 | — | — | US | disclosed |
| US-20110268680-A1 | HEAT STABLE PROTEIN INGREDIENTS | UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2011-11-03 | — | — | US | disclosed |
| US-20110184147-A1 | ENZYME SUBSTRATE FOR LABELING OF PROTEIN | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2011-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110184147-A1 | ENZYME SUBSTRATE FOR LABELING OF PROTEIN | ASNS, FARSA, DNPEP | SLC1A3 847/4885SLC1A1 1342/4885MME 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.